without implanting a battery. The system includes software-based waveforms and is cleared by the U.S. FDA for both SCS and PNS indications. Therapy is managed through a smartphone app for patient control and system upgrades. Recent development includes a smaller version of the Therapy Disc to improve comfort and broaden applicability for patients needing peripheral nerve treatment.